Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Matthews

Showing results (151-160 of 293) with videos related to

Pageof 30
Sort By:
Antiviral Therapy|August 9, 2014
Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis CTanya L Applegate, Silvana Gaudieri, Anne Plauzolles, et al.
The Journal of Invasive Cardiology|February 18, 2016
Impact of Surgical Consultation on Outcomes in Hemodynamically Supported High-Risk Percutaneous Coronary Intervention: Insights From PROTECT II Randomized StudyDavid M Shavelle, Ajay J Kirtane, Theodore L Schreiber, et al.
Sexual Health|May 20, 2011
Participants' perspectives of high resolution anoscopyRichard J Hillman, Sarah Pett, Debbie Marriott, et al.
Journal of Viral Hepatitis|December 28, 2016
HCV reinfection incidence among individuals treated for recent infectionM Martinello, J Grebely, K Petoumenos, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 5, 2024
Effect of evolocumab in patients with chronic limb threatening ischemia (Evol-CLI study)Ashwat S Dhillon, Jorge Caro, Jongkyu Choi, et al.
AIDS Research and Therapy|March 13, 2012
Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in ThailandAnchalee Avihingsanon, Gail V Matthews, Sharon R Lewin, et al.
Journal of Medical Virology|July 22, 2014
Dynamics of HCV RNA levels during acute hepatitis C virus infectionBehzad Hajarizadeh, Jason Grebely, Tanya Applegate, et al.
World Journal for Pediatric & Congenital Heart Surgery|June 27, 2013
Anomalous coronary arteries: cardiovascular computed tomographic angiography for surgical decisions and planningJerold S Shinbane, Jabi Shriki, Fernando Fleischman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2019
Can Australia Reach the World Health Organization Hepatitis C Elimination Goal by 2025 Among Human Immunodeficiency Virus-positive Gay and Bisexual Men?David C Boettiger, Luisa Salazar-Vizcaya, Gregory J Dore, et al.
AIDS (London, England)|December 13, 2001
Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort studyGail V Matthews, Caroline A Sabin, Sundhiya Mandalia, et al.
Pageof 30

Showing results (151-160 of 293) with videos related to

Sort By:
Pageof 30
Antiviral Therapy|August 9, 2014
Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis CTanya L Applegate, Silvana Gaudieri, Anne Plauzolles, et al.
The Journal of Invasive Cardiology|February 18, 2016
Impact of Surgical Consultation on Outcomes in Hemodynamically Supported High-Risk Percutaneous Coronary Intervention: Insights From PROTECT II Randomized StudyDavid M Shavelle, Ajay J Kirtane, Theodore L Schreiber, et al.
Sexual Health|May 20, 2011
Participants' perspectives of high resolution anoscopyRichard J Hillman, Sarah Pett, Debbie Marriott, et al.
Journal of Viral Hepatitis|December 28, 2016
HCV reinfection incidence among individuals treated for recent infectionM Martinello, J Grebely, K Petoumenos, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 5, 2024
Effect of evolocumab in patients with chronic limb threatening ischemia (Evol-CLI study)Ashwat S Dhillon, Jorge Caro, Jongkyu Choi, et al.
AIDS Research and Therapy|March 13, 2012
Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in ThailandAnchalee Avihingsanon, Gail V Matthews, Sharon R Lewin, et al.
Journal of Medical Virology|July 22, 2014
Dynamics of HCV RNA levels during acute hepatitis C virus infectionBehzad Hajarizadeh, Jason Grebely, Tanya Applegate, et al.
World Journal for Pediatric & Congenital Heart Surgery|June 27, 2013
Anomalous coronary arteries: cardiovascular computed tomographic angiography for surgical decisions and planningJerold S Shinbane, Jabi Shriki, Fernando Fleischman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2019
Can Australia Reach the World Health Organization Hepatitis C Elimination Goal by 2025 Among Human Immunodeficiency Virus-positive Gay and Bisexual Men?David C Boettiger, Luisa Salazar-Vizcaya, Gregory J Dore, et al.
AIDS (London, England)|December 13, 2001
Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort studyGail V Matthews, Caroline A Sabin, Sundhiya Mandalia, et al.
Pageof 30